(b) TaqMan hPSC Scorecard gene expression profiling of pluripotency, endodermal, mesodermal and ectodermal fate-specifying genes in NCRM-5 (healthy control) and ND34391G (SNCA triplication) iPSCs compared to other established iPSC lines, ND38477C (PARK2 mutant) and NHDF-1 (healthy control).
(c) Scatterplots and corresponding correlation coefficients of hPSC ScoreCard Ct values for NCRM-5 (healthy control) and ND34391G (SNCA triplication) iPSCs compared to ND38477C (PARK2 mutant) and NHDF-1 (healthy control) iPSCs.
(d) Validation of doubled SNCA copy number in ND34391G (SNCA triplication) iPSCs, compared to NCRM-5 (healthy control) and NCRM-1 (healthy control) iPSCs by Type-it CNV SYBR Green qPCR. 
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CACCGAGCGGCGCTGCTGTTGGTGC AAACGCACCAACAGCAGCGCCGCTC
HTT TSS-1
CACCGTTGCGTCCCAGACGCTGCGC AAACGCGCAGCGTCTGGGACGCAAC
HTT TSS-2
CACCGCGTCCATCTTGGACCCGTCC AAACGGACGGGTCCAAGATGGACGC
HTT TSS-3 NCRM-5 (healthy control) and NCRM-1 (healthy control) iPSCs are distributed through RUDCR Infinite Biologics at Rutgers University and were obtained as feeder-free cryostocks from the NIH Center for Regenerative Medicine (NIH CRM). ND38477C (PARK2 mutant) iPSCs are distributed through the NINDS Repository Fibroblasts and iPSCs Collection and were obtained as a feeder-free cryostock from the Coriell Institute. NHDF-1 (healthy control) iPSCs were likewise obtained as a feeder-free cryostock from the James Martin Stem Cell Facility. Cells were thawed onto Matrigel-coated plates in E8 medium, supplemented with 10 µM ROCK inhibitor for the first 24 hours after thawing.
CACCGTGAATGGGGCTCTGGGCCGC AAACGCGGCCCAGAGCCCCATTCAC
For maintenance of feeder-free cultures, 100% E8 medium was replaced daily. When cells reached 70% confluence, they were passaged with 0.5 mM EDTA (Life Technologies) in calcium-and magnesium-free DPBS (Life Technologies). Cells were seeded at a subcultivation ratio between 1:6 and 1:24 in E8 medium, supplemented with 10 µM ROCK inhibitor for the first 24 hours after passaging.
Pluripotency Immunostaining
Immunostaining was performed as described in the methods section of the main article.
The following antibodies were used for pluripotency immunostaining: Nanog (PeproTech, 500-P236), Tra-1-60 (Millipore, MAB4360), Oct4 (Cell Signaling, 2750), goat anti-rabbit IgG Alexa Fluor 488 (Life Technologies, A-11034) and goat anti-mouse IgM 555 (Life Technologies, A-21426).
TaqMan hPSC Scorecard Analysis
For TaqMan hPSC Scorecard (Life Technologies) analysis, 20 µL of cDNA, made with 1 µg of RNA from each iPSC line (prepared as described in the methods section of the main article), was diluted in 610 µL of nuclease-free water. 630 µL of 2X TaqMan Fast Advanced Master Mix was added and 10 µL of the reaction mixture was loaded per well into the plate, using a fresh tip for each well. Cycling was performed on a StepOnePlus Real-Time PCR System (Life Technologies) under fast cycling conditions with the following program: 50°C for 2 min, 95°C for 20 sec and 40 cycles of 95°C for 1 sec and 60°C for 20 sec. Data were analyzed using hPSC Scorecard Analysis Software (Life Technologies).
CNV Quantification
Quantification of SNCA copy number was performed using Type-IT CNV SYBR Green (Qiagen) qPCR assays, per the manufacturer's instructions. Primers for CNV quantification were designed both within and outside the triplication region. Primer sequences are provided in Supplementary Table S2. 
